Did you know? This new HIV therapy can boost immunity

Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers at Yale University said.

By: ANI | | Published: August 17, 2018 12:29 pm

Turns out, a new HIV drug can reduce the viral replication and increase immune cells in individuals with advanced, drug-resistant HIV infection.

For some individuals with HIV, existing drug therapies fail to suppress the virus, leading to drug resistance and worsening disease. While several HIV drugs target the virus effectively, there has not been a new class of HIV drugs approved to combat the disease in a decade.

During the study, patients received a dose of ibalizumab, which is delivered intravenously, in addition to their failing regimen, for one week. After that period, they received ibalizumab in combination with optimized treatment regimens for six months.

The research team found that after one week on ibalizumab, the majority of the 40 patients (83%) enrolled in the study experienced a decrease in viral load, which refers to the amount of HIV detected in the blood. After 25 weeks, nearly half of patients saw viral load suppression dip below the level of detection. The researchers also reported an increase in CD4 T cells, which are a marker for immune strength. A single individual experienced an adverse event, which was felt to be ibalizumab-related and resulted in withdrawal from the study, the researchers said.

As the first monoclonal antibody approved to treat HIV, ibalizumab is a promising option for individuals who have tried several other drug therapies.

Because of its novel mechanism, ibalizumab will not interact negatively with other medications. It is also delivered intravenously every two weeks and lasts longer than current HIV drugs, which are taken daily by mouth.

Source: ANI

Image Source: Shutterstock

Published : August 17, 2018 12:29 pm

Read Disclaimer

Want to get rid of Haemorrhoids? Eat this!

After being on artificial lung support for more than a month despite a lung transplant woman gets new lease of life

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Want to get rid of Haemorrhoids? Eat this!

After being on artificial lung support for more than a month despite a lung transplant woman gets new lease of life

About The health Site

Useful Links